Biomedical subjects

Susan Ford

Publications and source records attributed to Susan Ford.

4 recordsLinked to original sources

PubMed2005

Tetramethylcyclopentadienylselenium derivatives.

Bis(1,2,3,4-tetramethylcyclopentadienyl)selane (1) has been prepared by the reaction of tetramethylcyclopentadienyllithium (Cp(t)Li) with selenium bis(diethyldithiocarbamate). Treatment of Cp(t)Li with elemental selenium, followed by air oxidation, led to loss of the allylic hydrogen atom, and formation of the novel tricyclic compound 1,4,5,6,7,10,11,12-octamethyltricyclo[7.3.0.0]-2,8-diselenadodeca-3,5,9,11-tetraene (2). The sulfur analogue of 2 has been obtained by a similar procedure. The X-ray crystal structures of compounds 1 and 2 have been determined, and the molecular geometry observed for has been probed using DFT calculations.

Journal Article↗

PubMed2004

Synthesis and properties of palladium diselenolenes: X-ray crystal structures of [Pd[SeC(R(1))=C(R(2))Se](PBu(3))(2)] [R(1), R(2) = (CH(2))(n), n = 4, 5, 6].

The reaction between [Pd(2)(dba)(3)] (dba = dibenzylideneacetone), tributylphosphine, and a bis(cycloalkeno)-1,4-diselenin leads to either a mononuclear diselenolene [Pd[SeC(R(1))=C(R(2))Se](PBu(3))(2)] or a dinuclear diselenolene [Pd(2)[SeC(R(1))=C(R(2))Se](2)(PBu(3))(2)] [R(1), R(2) = (CH(2))(n), n = 4, 5, 6] depending on the stoichiometry employed. Treatment of the dinuclear diselenolenes with 1,2-bis(diphenylphosphino)ethane (dppe) provides a high-yielding route to the mononuclear species [Pd[SeC(R(1))=C(R(2))Se](dppe)]. All new compounds have been characterized by standard spectroscopic and analytical techniques, in particular by multinuclear NMR spectroscopy; the structure of each of the mononuclear tributylphosphine complexes has been determined by X-ray crystallography. Computational studies show that the observed asymmetry of the diselenolenes in the solid state is a result primarily of intramolecular repulsive interactions between the ligands.

Journal Article↗

PubMed1993

Aplastic anemia associated with prolonged high-dose trimethoprim-sulfadiazine administration in two dogs.

Trimethoprim-sulfadiazine (TMP-SDZ) (Tribressin tablets 120 - 100 mg sulfadiazine, 20-mg trimethoprim [Coopers Animal Health, Inc., A Pitman-Moore Company, Mundelein, Ill.]) is a broad spectrum antibiotic combination effective in the treatment of bacterial pneumonia, urinary tract infections, pyoderma, meningitis, and prostatitis.(1) In clinical trials in puppies and adult dogs, TMP-SDZ was considered safe at both the manufacturer's recommended dose (15 mg/kg, b.i.d., or 30 mg/kg, u.i.d., per os for < 14 days(2)) and at 10 times that dose for 20 dayS.(3) Many infections, however, require prolonged high-dose therapy for resolution. The following study describes two cases of aplastic anemia and sepsis associated with intermittent, chronic (17-25 days), high-dose (25-30 mg/kg, b.i.d., per os) TMP-SDZ therapy recommended for the treatment of pyoderma.(4-7)

Journal Article↗

PubMedDate not supplied

Developing a comprehensive cancer center rehabilitation program.

As more oncology care is provided in the outpatient setting, cancer centers and oncology healthcare professionals are presented with greater opportunities to substantially enhance the quality of care given to patients. A diagnosis of cancer is a life-changing event that has many implications for the patient, as well as his or her family members. The stress of dealing with a new cancer diagnosis and the ensuing medical treatment can be overwhelming. Treatment for cancer may involve complex protocols, leaving patents mentally and physically exhausted. A multidisciplinary approach to the primary treatment plan-surgery, chemotherapy, and radiation therapy--is the standard of care. However, formalized rehabilitation programs for this patient population are unique. Many facilities rely on a centralized rehabilitation department within a medical center to meet the needs of oncology patients. Although this is the traditional approach, the growing complexity of cancer treatment provides an opportunity to enhance the rehabilitation process. The Gibbs Regional Cancer Center (GRCC), which is a part of Spartanburg Regional Healthcare System, teamed up with the hospital rehabilitation department to create a venue specifically designed for oncology patients. Described within this article is the developmental process of the GRCC Rehabilitation Program.

Cancer Care Facilities↗